Abstract
Inhibition of vascular endothelial growth factor (VEGF) by gene transfer techniques was effectively applied to control experimental tumor growth, whereas effects on systemic VEGF levels had not been investigated. Therefore, we evaluated the effect of VEGF inhibition by adenoviral-mediated gene delivery of a dominant-negative soluble fragment of FLK-1 (sFlk-1) on systemic VEGF levels, organ-specific VEGF-RNA expression and antitumor efficacy in a murine colorectal cancer (CRC) tumor model. Vector function of AdsFlk-1 was shown by Western blot analysis and transgene expression was documented over a time period of 42 days in the serum of treated mice. Although cell supernatant of CT26 cells contained considerable levels of VEGF, systemic VEGF levels in the serum of tumor-bearing mice remained unaffected. Interestingly, mice that were systemically treated with AdsFlk-1 showed a strong upraise of circulating VEGF, whereas VEGF remained at background levels in the control. Vascular endothelial growth factor was increased not only in tumor bearing but also in healthy, tumor-free mice. Vascular endothelial growth factor determination in liver tissue homogenates showed a 16.5-fold upraise in AdsFlk-1-treated animals as compared to the A...Continue Reading
References
Jul 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C QianJ Prieto
Apr 1, 1993·The American Journal of Physiology·W T MonacciE H Oldfield
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·H H Marti, W Risau
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·C J KuoR C Mulligan
Jul 5, 2002·Nature·Anton P McCaffreyMark A Kay
Jul 13, 2002·Circulation Research·Errol S WijelathMichael Sobel
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold F Dvorak
Dec 5, 2002·Surgery·Jennifer F TsengRichard C Mulligan
Dec 24, 2002·Cancer Biology & Therapy·Christian M BeckerBruce R Zetter
Apr 2, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·M Gabriela KramerJesus Prieto
May 20, 2003·The Journal of Pathology·Vickie HanrahanStephen B Fox
Sep 19, 2003·Trends in Biochemical Sciences·Michael J CrossLena Claesson-Welsh
Oct 1, 2003·Angiogenesis·K GuptaR P Hebbel
Apr 17, 2004·Cancer Research·Maider ZabalaM Gabriela Kramer
Sep 18, 2004·Cancer Research·Guido BocciRobert S Kerbel
Jan 25, 2005·Transplantation·Yuki SatoEiji Kobayashi
Mar 12, 2005·The Lancet Oncology·Ed Susman
Apr 12, 2005·The Oncologist·Alan Venook
May 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Esther RaskopfVolker Schmitz
Aug 16, 2005·Gut·M OckerD Schuppan
Jan 27, 2006·The American Journal of Pathology·Arindel S R MaharajPatricia A D'Amore
Citations
Jul 14, 2012·Cancer Gene Therapy·K-J ZhangX-Y Liu
Feb 9, 2007·Gene Therapy·J HannayD Lev
Jan 6, 2012·Nucleic Acid Therapeutics·Emine SalvaJülide Akbuğa
May 23, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Tony E WalshePatricia A D'Amore
Apr 9, 2008·Molecular Medicine·Miroslaw KornekVolker Schmitz
Aug 12, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Alexandre BozecGérard Milano
Oct 11, 2008·Journal of Hepatology·Esther RaskopfVolker Schmitz
Oct 29, 2009·Virology Journal·Nicola ImelliUrs F Greber
Oct 5, 2016·Archives of Virology·Soheila MoeiniAmir Ghaemi
Aug 17, 2016·Oncotarget·Lejla AlidzanovicChristine Brostjan
Jul 22, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ravindra GujarPradip Sen
Feb 9, 2017·AMB Express·Awatef Taktak-BenAmarAli Gargouri
Aug 26, 2017·Molecular Cancer Therapeutics·Allison S HarneyJohn S Condeelis
May 1, 2021·Frontiers in Immunology·Saeed AsiryGeorge S Karagiannis
May 25, 2021·Angiogenesis·Julia C F QuintanilhaFederico Innocenti